Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paula I. González Ericsson

Extended Adjuvant Therapy With Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Related publications

Pcn180 - Pharmacoeconomic Assessment of Fulvestrant Versus Dd (Doxorubicin, Docetaxel) Therapy in Postmenopausal Women With Metastatic Er (+) Her2 (-) Breast Cancer in Ukraine

English

Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?

Oncology in Clinical Practice

Oncology

2019

English

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

New England Journal of Medicine

Medicine

2005

English

Correction To: Unexpected Benefit From Alpelisib and Fulvestrant in a Woman With Highly Pre-Treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer

Clinical Drug Investigation

Medicine

Pharmacology

2019

English

Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial

English

Optimal Adjuvant Endocrine Treatment of ER+/HER2+ Breast Cancer Patients by Age at Diagnosis: A Population-Based Cohort Study

European Journal of Cancer

Cancer Research

Oncology

2018

English

Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER–/PR– Breast Cancers, a Chromosome 17 C-HPP Study

Journal of Proteome Research

Biochemistry

Chemistry

2015

English

Breast Cancer Subtypes Among Iraqi Patients: Identified by Their ER, PR and HER2 Status

Journal of the faculty of medicine baghdad

2017

English

PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paula I. González Ericsson

Extended Adjuvant Therapy With Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial

Related publications

Pcn180 - Pharmacoeconomic Assessment of Fulvestrant Versus Dd (Doxorubicin, Docetaxel) Therapy in Postmenopausal Women With Metastatic Er (+) Her2 (-) Breast Cancer in Ukraine

Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Correction To: Unexpected Benefit From Alpelisib and Fulvestrant in a Woman With Highly Pre-Treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer

Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial

Optimal Adjuvant Endocrine Treatment of ER+/HER2+ Breast Cancer Patients by Age at Diagnosis: A Population-Based Cohort Study

Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER–/PR– Breast Cancers, a Chromosome 17 C-HPP Study

Breast Cancer Subtypes Among Iraqi Patients: Identified by Their ER, PR and HER2 Status

PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer